Sab Biotherapeutics Inc (SABS) Stock Price, Quote & News

Company Profile

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte glo...

Industry: Biotechnology

Sector: Healthcare

Phone: 605 679 6980

Website: www.sabbiotherapeutics.com

Address:

777 W 41st St., Miami Beach, United States

Love_To_Learn Nov. 14 at 6:03 PM

$SABS detonating an update manually soon ish it will not b organic

0 · Reply

d_risk Nov. 14 at 12:38 PM

$SABS - SAB Biotherapeutics, Inc. - 10Q - Updated Risk Factors SABS warns that shifts at the FDA or other regulators could disrupt hiring, delay product development, and hinder agency functions critical to their business, posing new operational risks. #Biotechnology #OperationalRisk #ProductDevelopment #FDA #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/SABS/10-Q/2025-11-13

1 · Reply

JTebow_CWS Nov. 13 at 2:31 PM

$SABS Best short explanation I’ve seen in a video. Excellent find sir. Thank for sharing with the group.

0 · Reply

stockboyaisle1 Nov. 13 at 2:26 AM

$SABS https://www.youtube.com/watch?v=rfAEzaKDmis

0 · Reply

stockboyaisle1 Nov. 13 at 1:52 AM

$SABS Slowly but surely: https://youtube.com/shorts/0yLS9LiRvME?si=hLO0_TbqDoMGtG0r

0 · Reply

DDiamond_Handz Nov. 12 at 10:08 PM

$SABS

0 · Reply

JTebow_CWS Nov. 12 at 6:22 PM

$SABS Register to listen to Fire Side Chat. https://event.webcasts.com/starthere.jsp?ei=1740267&tp_key=4aa7cbbaa6&tp_special=8

0 · Reply

Nicks_pics Nov. 12 at 4:20 PM

$SABS Extreme low volume algo dumping on all my growth tickers this morning but SABS holding strong 💪. Someone with institutional capital is likely accumulating very quietly.

0 · Reply

JTebow_CWS Nov. 10 at 6:46 PM

$SABS $SNY

1 · Reply

DDiamond_Handz Nov. 7 at 10:03 PM

$SABS

0 · Reply

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

Nov 4, 2025, 8:30 AM EST - 12 days ago

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

Nov 4, 2025, 8:00 AM EST - 12 days ago

SAB BIO to Participate in Upcoming Investor Conferences

Sep 19, 2025, 7:24 AM EDT - 2 months ago

SAB BIO Highlights Data in Multiple Presentations at EASD

Sep 3, 2025, 4:05 PM EDT - 2 months ago

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

Aug 7, 2025, 7:30 AM EDT - 3 months ago

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

Jul 21, 2025, 7:30 AM EDT - 4 months ago

SAB BIO Announces Oversubscribed $175 Million Private Placement

May 9, 2025, 9:00 AM EDT - 6 months ago

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

Mar 31, 2025, 7:32 AM EDT - 8 months ago

SAB BIO Reports Full Year 2024 Operating and Financial Results

Jan 28, 2025, 3:40 PM EST - 10 months ago

Why Is SAB BIO Stock Trading Lower On Tuesday?

Jan 28, 2025, 7:00 AM EST - 10 months ago

SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142

Jan 23, 2025, 7:00 AM EST - 10 months ago

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

Nov 6, 2024, 5:05 PM EST - 1 year ago

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

Sep 13, 2024, 7:00 AM EDT - 1 year ago

SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference

Sep 4, 2024, 7:05 AM EDT - 1 year ago

SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting

Aug 8, 2024, 5:51 PM EDT - 1 year ago

SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates

Aug 5, 2024, 7:30 AM EDT - 1 year ago

SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes

Jul 31, 2024, 7:30 AM EDT - 1 year ago

SAB BIO Appoints Lucy To as Chief Financial Officer

Jun 20, 2024, 7:20 AM EDT - 1 year ago

SAb Biotherapeutics Rebrands as SAB BIO

Jun 18, 2024, 1:10 PM EDT - 1 year ago

SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions

May 30, 2024, 4:45 PM EDT - 1 year ago

SAB Biotherapeutics Announces Departure of Chief Financial Officer

May 21, 2024, 7:15 AM EDT - 1 year ago

FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics

May 20, 2024, 5:45 PM EDT - 1 year ago

SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates

May 6, 2024, 7:15 AM EDT - 1 year ago

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors

Apr 16, 2024, 7:15 AM EDT - 1 year ago

SAB Biotherapeutics Provides SAB-142 Trial Update

Apr 8, 2024, 7:15 AM EDT - 1 year ago

SAB Biotherapeutics to Present at INNODIA Annual Meeting

Apr 4, 2024, 7:15 AM EDT - 1 year ago

SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference

Mar 29, 2024, 7:15 AM EDT - 1 year ago

SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results

Mar 25, 2024, 10:15 AM EDT - 1 year ago

SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment

Feb 23, 2024, 8:00 AM EST - 1 year ago

SAB Biotherapeutics to Present at the BIO CEO & Investor Conference

Feb 8, 2024, 8:00 AM EST - 1 year ago

SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 2, 2024, 7:30 AM EST - 1 year ago

SAB Biotherapeutics Announces Executive Leadership Change

Jan 23, 2024, 5:58 PM EST - 1 year ago

SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jan 2, 2024, 4:30 PM EST - 2 years ago

SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split

Nov 29, 2023, 7:30 AM EST - 2 years ago

SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes

Nov 20, 2023, 7:30 AM EST - 2 years ago

SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors

Nov 14, 2023, 7:30 AM EST - 2 years ago

SAB Biotherapeutics Announces Completion of $67.1 Million Financing to Advance Potential Disease-Modifying Treatment for Type 1 Diabetes

Nov 14, 2023, 7:15 AM EST - 2 years ago

SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company Updates

Nov 9, 2023, 7:30 AM EST - 2 years ago

SAB Biotherapeutics to Present at Piper Sandler Healthcare Conference

Oct 24, 2023, 7:30 AM EDT - 2 years ago

SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer

Love_To_Learn Nov. 14 at 6:03 PM

$SABS detonating an update manually soon ish it will not b organic

0 · Reply

d_risk Nov. 14 at 12:38 PM

1 · Reply

JTebow_CWS Nov. 13 at 2:31 PM

$SABS Best short explanation I’ve seen in a video. Excellent find sir. Thank for sharing with the group.

0 · Reply

stockboyaisle1 Nov. 13 at 2:26 AM

$SABS https://www.youtube.com/watch?v=rfAEzaKDmis

0 · Reply

stockboyaisle1 Nov. 13 at 1:52 AM

$SABS Slowly but surely: https://youtube.com/shorts/0yLS9LiRvME?si=hLO0_TbqDoMGtG0r

0 · Reply

DDiamond_Handz Nov. 12 at 10:08 PM

$SABS

0 · Reply

JTebow_CWS Nov. 12 at 6:22 PM

$SABS Register to listen to Fire Side Chat. https://event.webcasts.com/starthere.jsp?ei=1740267&tp_key=4aa7cbbaa6&tp_special=8

0 · Reply

Nicks_pics Nov. 12 at 4:20 PM

$SABS Extreme low volume algo dumping on all my growth tickers this morning but SABS holding strong 💪. Someone with institutional capital is likely accumulating very quietly.

0 · Reply

JTebow_CWS Nov. 10 at 6:46 PM

$SABS $SNY

1 · Reply

DDiamond_Handz Nov. 7 at 10:03 PM

$SABS

0 · Reply

Quid_Pro_Quo Nov. 5 at 8:43 PM

$SABS 3.25 at close?

0 · Reply

SPYmyQQQ Nov. 5 at 8:33 PM

💊 🚀 $SABS up ⬆️59.05% since our entry $2.10 on Sep 25, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

JTebow_CWS Nov. 5 at 12:30 PM

$SABS Lectures in Montreal Canada starting today.

0 · Reply

JTebow_CWS Nov. 5 at 12:23 PM

$SABS Solid PhD experience. First lecture in Montréal, Canada this morning. https://podcasts.apple.com/us/podcast/eric-sandhurst-the-future-of-south-dakota-biotechnology/id1375764701?i=1000508636780

1 · Reply

JTebow_CWS Nov. 4 at 9:20 PM

$SABS $SNY LinkedIn post.

0 · Reply

JTebow_CWS Nov. 4 at 5:10 PM

$SABS Announced this morning. Miami and Boston lectures. Molecular and cellular biology headquarters.

0 · Reply

JTebow_CWS Nov. 3 at 11:23 PM

$SABS $SNY Older but still an excellent podcast. Appreciate Sanofi cash backing. https://podcasts.apple.com/us/podcast/empowered-patient-podcast/id1037463498?i=1000477446749

1 · Reply

stockboyaisle1 Nov. 1 at 8:13 PM

$SABS

0 · Reply